August 10, 2017 05:09 PM EDT
People
R&D
Pharma

Gush­ing red ink, biotech bil­lion­aire Soon-Sh­iong slash­es staff at NantHealth by 300, sells as­sets

John Carroll

Editor & Founder

Reel­ing from grow­ing loss­es and un­der the gun af­ter nu­mer­ous re­ports of self-deal­ing, biotech bil­lion­aire Patrick Soon-Sh­iong is slash­ing NantHealth’s $NH staff by 300 and …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Pfiz­er ends work on Sang­amo's he­mo­phil­ia gene ther­a­py, crush­ing biotech's hopes

Flag­ship biotech Va­lo Health ends 2024 with mid-stage fail

No­var­tis ends Phase 1 ra­dio­phar­ma tri­al; Solve Ther­a­peu­tics pur­sues $75M round

FDA ap­proves Lil­ly's Zep­bound for sleep ap­nea, like­ly crack­ing open Medicare mar­ket

Bris­tol My­er­s' TYK2 in­hibitor suc­ceeds in pair of Phase 3 pso­ri­at­ic arthri­tis tri­als

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

A service from the Financial Times